{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29359178", "DateRevised": {"Year": "2022", "Month": "03", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "11", "Day": "21"}], "Language": ["eng"], "ELocationID": ["1079132", "10.1155/2017/1079132"], "Journal": {"ISSN": "2356-6752", "JournalIssue": {"Volume": "2017", "PubDate": {"Year": "2017"}}, "Title": "Advances in medicine", "ISOAbbreviation": "Adv Med"}, "ArticleTitle": "The Impact of Saffron on Symptoms of Withdrawal Syndrome in Patients Undergoing Maintenance Treatment for Opioid Addiction in Sabzevar Parish in 2017.", "Pagination": {"StartPage": "1079132", "MedlinePgn": "1079132"}, "Abstract": {"AbstractText": ["Drug dependence is one of the serious problems around the world. Saffron is one of those beneficial medicinal plants which is embedded with a similar mechanism to methadone (e.g., inhibition of serotonin reuptake). Thus, it can be helpful in reducing the withdrawal symptoms. The aim of this study was to reduce the daily dose of methadone usage and reduce its side effects using saffron in the form of medicinal supplements.", "This study was categorized as a clinical trial. Accordingly, 44 clients of addiction treatment centers in Sabzevar parish were randomly selected to participate in this study in 2016-2017. While the experimental group was treated with methadone syrup and self-made saffron capsules, the control group received methadone syrup and placebo capsules.", "The results showed that the use of saffron and methadone alleviated the symptoms of withdrawal syndrome (<i>p<0</i>.001).", "Having reviewed the research participants, it was indicated that the introduction of saffron alleviated the symptoms of withdrawal syndrome in patients undergoing maintenance treatment for opioid addiction. Thus, it seems rational to make use of saffron in combination with methadone in order to alleviate the symptoms of withdrawal syndrome."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sabzevar University of Medical Sciences, Abaresh, Iran."}], "LastName": "Nemat Shahi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": ["0000-0002-2080-0545"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Health Department, Sabzevar University of Medical Sciences, Abaresh, Iran."}], "LastName": "Asadi", "ForeName": "Atefeh", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sabzevar University of Medical Sciences, Abaresh, Iran."}], "LastName": "Behnam Talab", "ForeName": "Elham", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sabzevar University of Medical Sciences, Abaresh, Iran."}], "LastName": "Nemat Shahi", "ForeName": "Mahbobeh", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Med", "NlmUniqueID": "101651448", "ISSNLinking": "2314-758X"}, "CommentsCorrectionsList": [{"RefSource": "Adv Med. 2020 Sep 19;2020:9208647. doi: 10.1155/2020/9208647", "PMID": "33062727"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hyman S. E., Malenka R. C. Addiction and the brain: the neurobiology of compulsion and persistence. Nature Reviews Neuroscience. 2001;2(10):695\u2013703. doi: 10.1038/35094560.", "ArticleIdList": ["10.1038/35094560", "11584307"]}, {"Citation": "De Vries T. J., Shippenberg T. S. Neural systems underlying opiate addiction. Journal of Neuroscience. 2002;22(9):3321\u20133325.", "ArticleIdList": ["PMC6758389", "11978806"]}, {"Citation": "Cami J., Farre M. Drug addiction. New England Journal of Medicine. 2003;349(10):975\u2013986. doi: 10.1056/NEJMra023160.", "ArticleIdList": ["10.1056/NEJMra023160", "12954747"]}, {"Citation": "Nestler E. J. Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience. 2001;2(2):119\u2013128. doi: 10.1038/35053570.", "ArticleIdList": ["10.1038/35053570", "11252991"]}, {"Citation": "Koob G. F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Sciences. 1992;13(5):177\u2013184. doi: 10.1016/0165-6147(92)90060-J.", "ArticleIdList": ["10.1016/0165-6147(92)90060-J", "1604710"]}, {"Citation": "Robinson T. E., Berridge K. C. Addiction. Annual Review of Psychology. 2003;54:25\u201353. doi: 10.1146/annurev.psych.54.101601.145237.", "ArticleIdList": ["10.1146/annurev.psych.54.101601.145237", "12185211"]}, {"Citation": "Stolerman I. Drugs of abuse: behavioral principles, methods and terms. Trends in Pharmacological Sciences. 1992;13(5):170\u2013176. doi: 10.1016/0165-6147(92)90059-F.", "ArticleIdList": ["10.1016/0165-6147(92)90059-F", "1604709"]}, {"Citation": "Makri A., Norouzi A. The Guide on Methadone Maintenance Treatment in Addicts. Irsa Publications; 2013."}, {"Citation": "Nestler E. J. Molecular mechanisms of opiate and cocaine addiction. Current Opinion in Neurobiology. 2010;7(5):713\u2013719. doi: 10.1016/S0959-4388(97)80094-3.", "ArticleIdList": ["10.1016/S0959-4388(97)80094-3", "9384550"]}, {"Citation": "Dole V. P., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. Journal of the American Medical Association. 1965;193(8):646\u2013650. doi: 10.1001/jama.1965.03090080008002.", "ArticleIdList": ["10.1001/jama.1965.03090080008002", "14321530"]}, {"Citation": "Tavakoli M., Sahaf R., Farhoudian A., Bakhtavar Y., Farhadi M. The influence of detoxification on the quality of life in substance addicts lives with 40-65 years of age referring to the charity. Salmand: Iranian Journal of Ageing. 2012;6:34\u201340."}, {"Citation": "Hojjati H., Aloustani S., Akhondzadeh G., Heidari B., Sharif-Nia H. Study of mental health and its relation with quality of life in addicts. Journal of Shahid Sadoughi University of Medical Sciences. 2010;18:207\u2013214."}, {"Citation": "Carol M. C., Onken L. S. Behavioral therapies for substance abuse. American Journal of Psychiatry. 2005;162(8):1452\u20131460. doi: 10.1176/appi.ajp.162.8.1452.", "ArticleIdList": ["10.1176/appi.ajp.162.8.1452", "PMC3633201", "16055766"]}, {"Citation": "Zargari A. Medicinal Plants. 6th. Iran: University of Tehran Press; 1996."}, {"Citation": "Noorbala A. A., Akhondzadeh S., Tahmacebi-Pour N., Jamshidi A. H. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Journal of Ethnopharmacology. 2005;97(2):281\u2013284. doi: 10.1016/j.jep.2004.11.004.", "ArticleIdList": ["10.1016/j.jep.2004.11.004", "15707766"]}, {"Citation": "Sarris J., Panossian A., Schweitzer I., Stough C., Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. European Neuropsychopharmacology. 2011;21(12):841\u2013860. doi: 10.1016/j.euroneuro.2011.04.002.", "ArticleIdList": ["10.1016/j.euroneuro.2011.04.002", "21601431"]}, {"Citation": "Maj M. Development and validation of the current concept of major depression. Psychopathology. 2012;45(3):135\u2013146. doi: 10.1159/000329100.", "ArticleIdList": ["10.1159/000329100", "22399134"]}, {"Citation": "Sepehrmanesh Z., Ahmadvand A., Ghoreyshi F., Mousavi G. Personality traits of IV drug abusers of Kashan prison. Feyz Journal of Kashan University of Medical Sciences. 2008;12(1):69\u201375."}]}], "History": [{"Year": "2017", "Month": "3", "Day": "4"}, {"Year": "2017", "Month": "8", "Day": "19"}, {"Year": "2017", "Month": "9", "Day": "13"}, {"Year": "2018", "Month": "1", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "11", "Day": "21"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29359178", "PMC5735591", "10.1155/2017/1079132"]}}]}